Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimise Treatment Duration in Genotype 1 Non-Cirrhotic Treatment-Naïve Patients with Chronic Hepatitis C Virus (2018)

First Author: Fawsitt C
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2018.04.043

Publication URI: http://dx.doi.org/10.1016/j.jval.2018.04.043

Type: Journal Article/Review

Parent Publication: Value in Health